Skip to main content
Clinical Trials/CTRI/2025/06/089750
CTRI/2025/06/089750
Recruiting
Not Applicable

Evaluating the Effect of Integrated Approach Along with Ayurvedic Formulation (Peedanil Gold) in Chronic Low Back Pain: Prospective, Open Label, Single Arm, Observational Study.

Patanjali Research Foundation3 sites in 1 country56 target enrollmentStarted: July 21, 2025Last updated:

Overview

Phase
Not Applicable
Status
Recruiting
Enrollment
56
Locations
3
Primary Endpoint
Changes in the severity of pain by using Visual Analogue Scale and disability level of back pain by using The Oswestry Disability Index.

Overview

Brief Summary

This is a prospective, open-label, single-arm, observational study. Subjects will be screened on the basis of Inclusion/Exclusion criteria and enrolled after obtaining written Informed consent. After enrollment,  the investigator will plan 7 days Panchkarma procedure, yoga and naturopathy treatment along with oral medication Peedanil Gold. After 7 days the subject will be continue Peedanil Gold oral medication for next 3 months and  the severity of pain and quality of life will be assessed by using specfic questionnaire at Day 30, Day 60 and Day 90 interval..

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18.00 Year(s) to 65.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Subjects who had been experiencing chronic back pain that had been pre diagnosed for longer than three months.
  • Patients with acute musculoskeletal spasm with low back pain due to Lumbar spondylosis osteoarthritis Acute lumbosacral strain Blunt superficial trauma prolapsed intervertebral disc.
  • Patients who are ready to give written informed consent and comply with the protocol requirements.

Exclusion Criteria

  • Previous back surgery Diabetic and diagnosed with CLBP as a result of organic spine diseases, such as primary or secondary cancer chronic infections as identified by lumbar spine X rays chronic diseases like tuberculosis renal disease hemorrhagic sickness inflammatory low back pain and acute rheumatoid arthritis were not included in this study.
  • Patients with acute muscle spasms who need parenteral therapy surgery or hospital admissions for management.
  • Pregnant or lactating women.
  • Patients are unwilling or unable to comply with the study procedures.

Outcomes

Primary Outcomes

Changes in the severity of pain by using Visual Analogue Scale and disability level of back pain by using The Oswestry Disability Index.

Time Frame: From Baseline to Day 7 Day 30 Day 60 and Day 90

Secondary Outcomes

  • Changes in the Quality of life by using WHOQOL-BREF(From Baseline to Day 7 Day 30 Day 60 and Day 90)

Investigators

Sponsor Class
Research institution
Responsible Party
Principal Investigator
Principal Investigator

Dr Ajay Singh

Patanjali Ayurveda Hospital

Study Sites (3)

Loading locations...

Similar Trials